Search for: "Teva Pharmaceuticals"
Results 1261 - 1280
of 1,430
Sort by Relevance
|
Sort by Date
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
13 Dec 2008, 7:10 am
-based Triangle Pharmaceuticals Inc. licensed the product. [read post]
12 Dec 2008, 8:42 am
Teva Pharms. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic… [read post]
Roche Loses Drug Litigation Lawsuit and Is Ordered to Pay Almost $13 Million to Three Accutane Users
12 Dec 2008, 1:58 am
Roche Loses Fourth Accutane Trial, Ordered to Pay 3 IBD Victims, $12.9 Million, News Inferno, November 21, 2008 Pharma Roundup: Lawsuit for Roche, Teva Troubles for AstraZeneca, and More, BNET, November 19, 2008 Related Web Resources: Roche Pharmaceuticals Accutane, Drugs.com Inflammatory Bowel Disease, FamilyDoctor.org [read post]
Roche Loses Drug Litigation Lawsuit and Is Ordered to Pay Almost $13 Million to Three Accutane Users
12 Dec 2008, 1:58 am
Roche Loses Fourth Accutane Trial, Ordered to Pay 3 IBD Victims, $12.9 Million, News Inferno, November 21, 2008 Pharma Roundup: Lawsuit for Roche, Teva Troubles for AstraZeneca, and More, BNET, November 19, 2008 Related Web Resources: Roche Pharmaceuticals Accutane, Drugs.com Inflammatory Bowel Disease, FamilyDoctor.org [read post]
11 Dec 2008, 10:30 pm
(DRL); and Teva Pharmaceuticals USA, Inc. [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360)… [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]
26 Nov 2008, 7:57 am
Teva Pharmaceuticals USA, 1-08-cv-00426 (DED November 24, 2008, Report & Recommendation). [read post]
24 Nov 2008, 3:28 pm
“Who do you think was the country's biggest supplier of prescription drugs in 2007? [read post]
24 Nov 2008, 2:09 am
Teva Pharmaceuticals USA, Inc. et al.1:08-cv-06659; filed November 20, 2008 in the Northern District of IllinoisInfringement of U.S. [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings) (Hal… [read post]
21 Nov 2008, 5:49 am
" The 12-page paper, entitled "Proper Duration of Data Exclusivity for Generic Biologics: A Critique," was funded by Teva Pharmaceuticals (see Teva press release), which also funded a report on data exclusivity released last September (see "BU Economics Professor... [read post]
20 Nov 2008, 8:29 pm
Note that financial support for this white paper was provided by Teva Pharmaceuticals. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
10 Nov 2008, 11:20 am
However it was undisputed that Conte took only Teva Pharmaceutical USA, Inc. [read post]
8 Nov 2008, 2:24 pm
Japanese drug major, Takeda Pharmaceuticals Co. has won a US appeals court ruling that delays Teva Pharmaceutical Industries Ltd. from selling a generic version of the heartburn drug Prevacid, generically Lansoprazole until next year. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
